
While there are concerns that America is losing the war with obesity, there are other signs, like the City of Philadelphia's successful implementation of a beverage tax.
Mary Caffrey is the Executive Editor for The American Journal of Managed Care® (AJMC®). She joined AJMC® in 2013 and is the primary staff editor for Evidence-Based Oncology, the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for AJMC®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for AJMC readers.
Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on LinkedIn.
While there are concerns that America is losing the war with obesity, there are other signs, like the City of Philadelphia's successful implementation of a beverage tax.
The researchers found that the shares of Americans who weighed too much rose over time, but the share who were trying to lose weight did not.
As Republicans in Congress move to scale back Medicaid, a New Jersey healthcare quality group lays out a blueprint to move forward with reform while saving money.
The author suggested that it was more important to understand the hormonal changes behind the early onset of menstruation and associated weight gain.
FDA has until December 2017 to act on the applications, which include a combination of the SGLT2 inhibitor and the top-selling Januvia.
An estimated 86 million people in the United States have prediabetes, but they typically have no symptoms. The long-term medical and economic complications of diabetes are significant, costing the country $245 billion a year.
Recent studies have linked yoga and mindfulness with reduced stress, improved glycemic control, and even lower medical costs. Should these low-cost practices find ways to standardize to meet payers' needs? Or is it managed care that needs to adapt?
While the Ohio governor is getting more attention for his efforts to keep federal funds for Medicaid expansion, he's quietly working just as hard on maintaining the momentum toward value-based care.
The House GOP plan would let insurers charge older adults more while younger ones pay less. But low-income Americans nearing retirement age would see tax credits sliced in half at a time when premiums would rise.
US and European guidelines recommend 150 minutes per week of moderate physical activity.
The lack of measurement goes against the trend toward accountability in healthcare. Studies show there are savings to be found in post-acute settings.
The study points to an additional tool that could help prevent at-risk patients from progressing to diabetes.
For some time, studies have shown a link between elevated stress and obesity. Measuring cortisol levels in the hair may be a better way to evaluate chronic stress, since the hormone level will not fluctuate from day to day.
The bill circulating Friday would allow insurers to charge older Americans 5 times what the youngest group pays; insurers could charge anyone with a lapse in coverage 30% more to re-enter the market.
The shift is almost entirely due to a boost of support from independents. Respondents also overwhelmingly support keeping funds for Medicaid expansion.
The results are important given the concentration of Medicare beneficiaries who are in Medicaid and being treated for multiple chronic conditions.
The study adds to the growing body of evidence linking heart disease and diabetes to dementia.
The results from the United Kingdom support CMS' decision to add a payment code for collaborative care to this year's Medicare Physician Fee Schedule.
The results follow a separate report that outlined the reasons why low-income workers don't seek preventive care, and what can be done.
A panel discussion about the challenges of health information technology at the 5th annual Patient-Centered Oncology Care® meeting also identified opportunities for providers to leverage better solutions.
The announcements come as Medicare is set to start reimbursing the Diabetes Prevention Program on January 1, 2018.
Pam Mangat, MS, associate director for the TAPUR study in the research and analysis division of the American Society of Clinical Oncology, offered an update on the study at the 5th annual Patient-Centered Oncology Care® meeting.
Two surveys, one each for patients and providers, reveal gaps between patient confidence to manage disease or pain and what they'd like to see from their physicians.
This small study found sustained weight loss of 10% of body weight in patients who were overweight but not obese, along with improvements in glycemic control and quality of life that exceeded patients taking medication only.
The policy brief outlines House GOP thinking on a universal, refundable, and portable tax credit, state-based high-risk pools, and how to repeal Medicaid expansion. But many specifics, including what it would cost a typical family, are unclear.
Researchers examined how genetic variants linked to type 2 diabetes behave in their environment, and the results pointed to a molecule that affects how pancreatic islet cells "read" the genes.
The study found that the average healthcare cost of an unnecessary shock was $4470, and 42% of the patients captured in the data received an inappropriate shock. The group included 41% in Medicare.
An author in JAMA points out some caveats to a ground-breaking trial.
Moments after the bill cleared the General Assembly, NJ Governor Chris Christie signed into law requirements that insurers pay for 6 months of treatment, limit the first opioid script to 5 days, and educate prescribers on the dangers of addiction.
The legislature is expected to give final passage to the nation's strictest treatment mandates and a 5-day cap on the initial opioid prescription. Governor Chris Christie's plan has met little resistance, even though the cost is unknown.
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.